Sterling Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Sterling Capital Management's RPRX Position: Q3 2026 in Review
Sterling Capital Management reduced its Royalty Pharma (RPRX) stake by 60% in Q3 2026, selling an estimated $2.34M and leaving 26,347 shares worth $1.54M. The position accounts for 0.03% of the portfolio, ranked #371.
Sterling Capital Management first reported a position in RPRX in Q3 2024 and has held it in 9 quarters since. The position peaked at $3.7M in Q2 2026. 705 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Sterling Capital Management held 26,347 shares of Royalty Pharma worth $1.54M as of Q3 2026.
- Sterling Capital Management sold 39,687 Royalty Pharma shares in Q3 2026, an estimated $2.34M.
- Royalty Pharma made up 0.03% of Sterling Capital Management's portfolio in Q3 2026, its #371 holding.
- Sterling Capital Management first reported a position in Royalty Pharma in Q3 2024 and has held it in 9 quarters since.
- Sterling Capital Management's Royalty Pharma position peaked at $3.7M in Q2 2026.
- 705 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.